Profil

Bellahcene Akeila

GIGA Cancer - Metastases Research Laboratory

Département des sciences biomédicales et précliniques

See author's contact details
ORCID
0000-0001-9154-7631
Main Referenced Co-authors
Castronovo, Vincenzo  (147)
Peulen, Olivier  (86)
Maloujahmoum, Naïma  (35)
Nokin, Marie-Julie  (35)
Agirman, Ferman  (33)
Main Referenced Keywords
Myoferlin (29); bone sialoprotein (18); breast cancer (14); Methylglyoxal (14); Cancer (11);
Main Referenced Unit & Research Centers
Giga-Cancer - ULiège [BE] (45)
d‐BRU - Dental Biomaterials Research Unit - ULiège [BE] (24)
GIGA-LRM - GIGA Cancer-Metastases Research Laboratory - ULiège [BE] (5)
Service d'Urologie CHU Liège (4)
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège [BE] (3)
Main Referenced Disciplines
Oncology (142)
Biochemistry, biophysics & molecular biology (79)
Pharmacy, pharmacology & toxicology (10)
Urology & nephrology (10)
Rheumatology (6)

Publications (total 184)

The most downloaded
1031 downloads
Rademaker, G.* , Boumahd, Y.* , Peiffer, R., Anania, S., Wissocq, T., Liégeois, M., Luis, G., Sounni, N. E., Agirman, F., Maloujahmoum, N., De Tullio, P., Thiry, M., Bellahcene, A., Castronovo, V., & Peulen, O. (July 2022). Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. Redox Biology, 53, 102324. doi:10.1016/j.redox.2022.102324 https://hdl.handle.net/2268/289926

The most cited

737 citations (Scopus®)

Wood, J., Bonjean, K., Ruetz, S., Bellahcene, A., Devy, L., Foidart, J.-M., Castronovo, V., & Green, J. R. (September 2002). Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. Journal of Pharmacology and Experimental Therapeutics, 302 (3), 1055-1061. doi:10.1124/jpet.102.035295 https://hdl.handle.net/2268/24080

Anania, S., Farnir, M., Peiffer, R., Boumahd, Y., Thiry, M., Agirman, F., Maloujahmoum, N., Bellahcene, A., & Peulen, O. (17 February 2024). Identification of myoferlin as a mitochondria-associated membranes component required for calcium signaling in PDAC cell lines. Cell Communication and Signaling, 22 (1), 133. doi:10.1186/s12964-024-01514-z
Peer reviewed

Mohring, V., Hubert, P., Ancion, M., Nokin, M.-J., Roncarati, P., Agirman, F., Maloujahmoum, N., Lardinois, F., Wissocq, T., Herfs, M., Peulen, O., Janji, B., & Bellahcene, A. (06 February 2024). Exploring the impact of methylglyoxal stress on tumor immunity [Poster presentation]. Séminaire Télévie 2024.

Lardinois, F., Crake, R., Bellier, J., Vara Messler, M., Richiardone, E., Peulen, O., Corbet, C., & Bellahcene, A. (27 October 2023). The role of methylglyoxal stress in developing acquired resistance to cetuximab in quadruple wild-type colorectal cancer [Poster presentation]. BACR - Belgian Association for Cancer Research.

Mohring, V., Hubert, P., Ancion, M., Nokin, M.-J., Roncarati, P., Agirman, F., Maloujahmoum, N., Lardinois, F., Wissocq, T., Herfs, M., Peulen, O., Janji, B., & Bellahcene, A. (27 October 2023). Methylglyoxal stress : a novel role in tumor immunity ? [Poster presentation]. Annual Meeting of the Belgian Association for Cancer Research (BACR).

Boumahd, Y., Colin, G., Peiffer, R., Gullo, C., Agirman, F., Maloujahmoum, N., Coucke, P., Bellahcene, A., & Peulen, O. (04 September 2023). Modulation of radiosensitivity by myoferlin pharmacological targeting in human pancreatic cancer cell lines [Poster presentation]. GIGA day 2023, Liège, Belgium.

Crake, R., Gasmi, I., Dehaye, J., Lardinois, F., Peiffer, R., Maloujahmoum, N., Agirman, F., KOOPMANSCH, B., D’Haene, N., Azurmendi Senar, O., Arsenijevic, T., Lambert, F., Peulen, O., Van Laethem, J.-L., & Bellahcene, A. (17 May 2023). Resistance to Gemcitabine in Pancreatic Cancer Is Connected to Methylglyoxal Stress and Heat Shock Response. Cells, 12 (10), 1414. doi:10.3390/cells12101414
Peer Reviewed verified by ORBi

Peiffer, R., Boumahd, Y., Gullo, C., Agirman, F., Maloujahmoum, N., Masamune, A., Letellier Elisabeth, Bellahcene, A., & Peulen, O. (03 May 2023). Myoferlin, a new drug target in pancreatic CAFs, promotes desmoplasia and tumor aggressiveness [Poster presentation]. Gordon Research Conference - Pancreatic Diseases, Lucca, Italy.

Dube, G., Tiamiou, A., Bizet, M., Boumahd, Y., Gasmi, I., Crake, R., Bellier, J., Nokin, M.-J., Calonne, E., Deplus, R., Wissocq, T., Peulen, O., Castronovo, V., Fuks, F., & Bellahcene, A. (31 March 2023). Methylglyoxal: a novel upstream regulator of DNA methylation. Journal of Experimental and Clinical Cancer Research, 42 (1), 78. doi:10.1186/s13046-023-02637-w
Peer reviewed

Lardinois, F., Crake, R., Bellier, J., Vara Messler, M., Richiardone, E., Peulen, O., Corbet, C., & Bellahcene, A. (21 February 2023). Role of methylglyoxal stress acquired resistance to cetuximab in quadruple wild-type colorectal cancer [Poster presentation]. Drugging and Regulating the MAP Kinase Pathway.

Peiffer, R., Boumahd, Y., Gullo, C., Crake, R., Letellier, E., Bellahcene, A., & Peulen, O. (22 December 2022). Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer. Cancers, 15 (1), 61. doi:10.3390/cancers15010061
Peer Reviewed verified by ORBi

Boumahd, Y., Rademaker, G., Peiffer, R., Anania, S., Gullo, C., Agirman, F., Maloujahmoum, N., Bellahcene, A., & Peulen, O. (30 September 2022). Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. Investigation of STAT3 involvement [Poster presentation]. BACR 2022, Gand, Belgium.

Mouziane, L., Crake, R., Maloujahmoum, N., Agirman, F., Roncarati, P., Herfs, M., & Bellahcene, A. (30 September 2022). Characterisation of methylglyoxal stress in human colorectal cancer and liver metastases using immunohistochemistry [Poster presentation]. BACR, Gent, Belgium.

Peiffer, R., Boumahd, Y., Anania, S., Gullo, C., Agirman, F., Maloujahmoum, N., Masamune Atsushi, Letellier Elisabeth, Bellahcene, A., & Peulen, O. (30 September 2022). The role of myoferlin in PDAC fibroblasts and desmoplasia [Poster presentation]. BACR - annual meeting 2022, Ghent, Belgium.

Lardinois, F., Crake, R., Bellier, J., Vara Messler, M., Richiardone, E., Peulen, O., Corbet, C., & Bellahcene, A. (30 September 2022). Role of methylglyoxal stress in acquired resistance to EGFR-targeted therapy in quadruple wild-type colorectal cancer [Poster presentation]. BACR - Belgian Association for Cancer Research, Ghent, Belgium.

Lardinois, F., Crake, R., Bellier, J., Vara Messler, M., Richiardone, E., Peulen, O., Corbet, C., & Bellahcene, A. (09 September 2022). Methylglyoxal Stress and Acquired Resistance to EGFR-Targeted Therapy in Colorectal Cancer [Poster presentation]. INTERUNIVERSITY PHD STUDENT DAY, Namur, Belgium.

Peiffer, R., Boumahd, Y., Anania, S., Gullo, C., Agirman, F., Maloujahmoum, N., Asamune, A., Letellier, E., Bellahcene, A., & Peulen, O. (06 September 2022). The role of myoferlin in pancreatic cancer fibroblasts and desmoplasia [Poster presentation]. GIGA Day 2022, Liège, Belgium.

Mohring, V., Wissocq, T., Hubert, P., Herfs, M., Tiamiou, A., Hasmim Meriem, Nokin, M.-J., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (September 2022). Immunosuppressive effect of methylglyoxal stress in breast cancer [Paper presentation]. Annual meeting of the Belgian Association for Cancer Research, Belgium.

Rademaker, G.* , Boumahd, Y.* , Peiffer, R., Anania, S., Wissocq, T., Liégeois, M., Luis, G., Sounni, N. E., Agirman, F., Maloujahmoum, N., De Tullio, P., Thiry, M., Bellahcene, A., Castronovo, V., & Peulen, O. (July 2022). Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. Redox Biology, 53, 102324. doi:10.1016/j.redox.2022.102324
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Boumahd, Y., Rademaker, G., Peiffer, R., Anania, S., Agirman, F., Maloujahmoum, N., Bellahcene, A., & Peulen, O. (22 June 2022). Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells [Poster presentation]. EACR 2022.
Peer reviewed

Lardinois, F., Crake, R., Bellier, J., Vara Messler, M., Richiardone, E., Peulen, O., Corbet, C., & Bellahcene, A. (22 June 2022). Acquired resistance to Cetuximab in quadruple wild-type colorectal cancer: role of methylglyoxal stress [Poster presentation]. EACR - European Association for Cancer Research, Séville, Spain.

Mohring, V., Wissocq, T., Hubert, P., Herfs, M., Tiamiou, A., Hasmim, M., Nokin, M.-J., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (21 June 2022). Methylglyoxal reshapes breast tumor immune microenvironment [Poster presentation]. European association for cancer research congress 2022, Séville, Spain.

Peiffer, R., Anania, S., Boumahd, Y., Agirman, F., Maloujahmoum, N., Masamune, A., Letellier, E., Bellahcene, A., & Peulen, O. (June 2022). The oncoprotein myoferlin as potential new participant in myCAF activity in pancreatic cancer [Poster presentation]. EACR 2022, Sevilla, Spain.

Chiavarina, B., Ronca, R., Otaka, Y., Sutton, R. B., Rezzola, S., Yokobori, T., Chiodelli, P., Souche, R., Pourquier, D., Maraver, A., Faa, G., Khellaf, L., Turtoi, E., Oyama, T., Gofflot, S., Bellahcene, A., Detry, O., Delvenne, P., Castronovo, V., ... Turtoi, A. (March 2022). Fibroblast-derived prolargin is a tumor suppressor in hepatocellular carcinoma. Oncogene, 41 (10), 1410-1420. doi:10.1038/s41388-021-02171-z
Peer Reviewed verified by ORBi

Rademaker, G., Costanza, B., Pyr Dit Ruys, S., Peiffer, R., Agirman, F., Maloujahmoum, N., Vertommen, D., Turtoi, A., Bellahcene, A., Castronovo, V.* , & Peulen, O.*. (2022). Paladin, overexpressed in colon cancer, is required for actin polymerisation and liver metastasis dissemination. Oncogenesis, 11, 42. doi:10.1038/s41389-022-00416-4
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Gullo, C., Boumahd, Y., Peiffer, R., Anania, S., Agirman, F., Maloujahmoum, N., Thiry, M., Bellahcene, A., & Peulen, O. (2022). Myoferlin controls beta actin cytoskeleton integrity in pancreas cancer [Paper presentation]. GIGA Day 2022, Liège, Belgium.

Boumahd, Y., Rademaker, G., Peiffer, R., Anania, S., Gullo, C., Agirman, F., Maloujahmoum, N., Bellahcene, A., & Peulen, O. (2022). Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. Investigation on the involvement of STAT3 [Paper presentation]. GIGA Day 2022, Liège, Belgium.

Mohring, V., Wissocq, T., Hubert, P., Herfs, M., Tiamiou, A., Hasmim Meriem, Nokin, M.-J., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (2022). Methylglyoxal regulates the recruitment of tumor-infiltrating immunosuppressive cells in breast cancer [Poster presentation]. PhD Day UNamur 2022, Belgium.

Boumahd, Y., Rademaker, G., Peiffer, R., Anania, S., Maloujahmoum, N., Agirman, F., Bellahcene, A., & Peulen, O. (14 December 2021). Myoferlin targeting primes ferroptosis in pancreatic cancer cells [Poster presentation]. GIGA cancer day.

Lardinois, F., Crake, R., Bellier, J., Vara Messler, M., Richiardone, E., Peulen, O., Corbet, C., & Bellahcene, A. (December 2021). Acquired resistance to EGFR-targeted therapy in quadruple wild-type colorectal cancer: role of methylglyoxal stress [Poster presentation]. GIGA-Cancer Day, Liège, Belgium.

Peiffer, R., Anania, S., Boumahd, Y., Agirman, F., Maloujahmoum, N., Bossicard, Y., Masamune, A., Letellier, E., Bellahcene, A., & Peulen, O. (December 2021). Deciphering the role of myoferlin in pancreatic stellate cells, key players in the pancreatic tumor microenvironment [Poster presentation]. GIGA-Cancer day 2021, Liège, Belgium.

Crake, R., Agirman, F., Arsenijevic, T., Maloujahmoum, N., Peulen, O., Van Laethem, J.-L., & Bellahcene, A. (14 October 2021). Improving pancreatic cancer response to gemcitabine by overcoming methylglyoxal driven suppression of AMPK [Poster presentation]. GIGA-Cancer Day, Liege, Belgium.
Peer reviewed

Tiamiou, A., Dube, G., Bizet, M., Bellier, J., Deplus, R., Nokin, M.-J., Wissocq, T., Gasmi, I., Peulen, O., Castronovo, V., Fuks, F., & Bellahcene, A. (09 June 2021). Methylglyoxal Induces An Epigenetic Deregulation leading to the Silencing of Tumor-Suppressor Genes in Breast Cancer [Poster presentation]. EACR Congress, Innovative Cancer Science, Better Outcomes through Resarch.

Anania, S., Boumahd, Y., Peiffer, R., Thiry, M., Hego, A., Maloujahmoum, N., Agirman, F., Bellahcene, A., & Peulen, O. (June 2021). Myoferlin, a promising therapeutic target in PDAC, is located in mitochondria-associated membranes [Poster presentation]. 27TH CONGRESS OF THE EUROPEAN ASSOCIATION FOR CANCER RESEARCH.

Peiffer, R., Anania, S., Boumahd, Y., Agirman, F., Maloujahmoum, N., Bossicard, Y., Masamune, A., Letellier, E., Bellahcene, A., & Peulen, O. (June 2021). New insights on the role of myoferlin in pancreatic stellate cells, the key orchestrators of pancreatic tumor microenvironment [Poster presentation]. EACR 2021.

Wissocq, T., Hubert, P., Tiamiou, A., Hasmim, M., Nokin, M.-J., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (May 2021). Methylglyoxal, a byproduct of glycolysis, modulates breast cancer immune landscape [Poster presentation]. 4th METABOLISM & CANCER SYMPOSIUM VIRTUAL MEETING, Bordeaux, France.

Chiavarina, B., Costanza, B., Ronca, R., Blomme, A., Rezzola, S., Chiodelli, P., Giguelay, A., Belthier, G., Doumont, G., Van Simaeys, G., Lacroix, S., Yokobori, T., Erkhem-Ochir, B., Balaguer, P., Cavailles, V., Fabbrizio, E., Di Valentin, E., Gofflot, S., Detry, O., ... Turtoi, A. (January 2021). Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis. Theranostics, 11 (4), 1626-1640. doi:10.7150/thno.51507
Peer Reviewed verified by ORBi

Luis, G.* , Godfroid, A.* , Nishiumi, S., Cimino, J., Blacher, S., Maquoi, E., Wery, C., Collignon, A., Longuespée, R., MONTERORUIZ, L., Dassoul, I., Maloujahmoum, N., Pottier, C., Mazzucchelli, G., De Pauw, E., Bellahcene, A., Yoshida, M., Noël, A., & Sounni, N. E. (2021). Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence. Redox Biology, 43, 102006. doi:10.1016/j.redox.2021.102006
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Anania, S., Peiffer, R., Rademaker, G., Hego, A., Thiry, M., Deldicque, L., Francaux, M., Maloujahmoum, N., Agirman, F., Bellahcene, A., Castronovo, V., & Peulen, O. (21 June 2020). Myoferlin is a yet unknown interactor of the mitochondrial dynamics’ machinery in pancreas cancer cells. Cancers, 12 (6), 1643. doi:10.3390/cancers12061643
Peer Reviewed verified by ORBi

Tiamiou, A., Dube, G., Bizet, M., Bellier, J., Deplus, R., Wissocq, T., Gasmi, I., Peulen, O., Castronovo, V., Fuks, F., & Bellahcene, A. (07 February 2020). Dicarbonyl stress induces an epigenetic deregulation leading to a pro-migratory phenotype in breast cancer [Poster presentation]. Belgium Assocication for Cancer Research (BACR), Bruxelles, Belgium.

Wissocq, T., Hubert, P., Caprasse, M., Nokin, M.-J., Noman, M. Z., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (07 February 2020). Methylglyoxal stress contributes to immunosuppression in breast cancer [Poster presentation]. Association Belge pour l'Etude du Cancer "A.B.E.C", Bruxelles, Belgium.

Bellier, J., Nokin, M.-J., Caprasse, M., Tiamiou, A., Blomme, A., Scheijen, J. L., KOOPMANSCH, B., MacKay, G. M., Chiavarina, B., Costanza, B., Rademaker, G., Durieux, F., Agirman, F., Maloujahmoum, N., Cusumano, P. G., LOVINFOSSE, P., Leung, H. Y., LAMBERT, F., Bours, V., ... Bellahcene, A. (04 February 2020). Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab. Cell Reports, 30 (5), 1400-1416.e6. doi:10.1016/j.celrep.2020.01.012
Peer Reviewed verified by ORBi

Anania, S., Rademaker, G., Peiffer, R., Hego, A., Deldicque, L., Maloujahmoum, N., Agirman, F., Bellahcene, A., Castronovo, V., & Peulen, O. (February 2020). Role of myoferlin in mitochondrial dynamics and metabolic fitness of pancreas cancer [Poster presentation]. BACR Annual Meeting 2020 - Cancer metastases: from bedside to bench, Brussels, Belgium.

Anania, S., Rademaker, G., Bellahcene, A., Castronovo, V., & Peulen, O. (December 2019). Role of myoferlin in mitochondrial dynamics and metabolic fitness of Pancreatic Ductal Adenocarcinoma [Poster presentation]. Second CIRM Scientific Day, Liège, Belgium.

Rademaker, G., Costanza, B., Anania, S., Agirman, F., Maloujahmoum, N., Bellahcene, A., Castronovo, V., & Peulen, O. (December 2019). Myoferlin Contributes to the Metastatic Phenotype of Pancreatic cancer cells by enhancing the migratory capacity through the control of oxidative phosphorylation [Poster presentation]. Cirm Annual meeting.

Rademaker, G., Costanza, B., Bellier, J., Herfs, M., Agirman, F., Maloujahmoum, N., Bellahcene, A., Castronovo, V., & Peulen, O. (26 November 2019). Myoferlin depletion induces DNA damage response and p53- dependent cell cycle arrest and apoptosis in colon cancer [Poster presentation]. Metabolism in Cancer and Stromal Cells (2nd edition), Leuven, Belgium.

Rademaker, G., Costanza, B., Anania, S., Agirman, F., Maloujahmoum, N., Bellahcene, A., Castronovo, V., & Peulen, O. (November 2019). Myoferlin Contributes to the Metastatic Phenotype of Pancreatic cancer cells by enhancing the migratory capacity through the control of oxidative phosphorylation [Poster presentation]. Bioforum Uliège.

Rademaker, G., Costanza, B., Anania, S., Agirman, F., Maloujahmoum, N., Bellahcene, A., Castronovo, V., & Peulen, O. (23 October 2019). Myoferlin Contributes to the Metastatic Phenotype of Pancreatic Cancer Cells by Enhancing Their Migratory Capacity Through the Control of Oxidative Phosphorylation [Poster presentation]. Pancreatic Cancer Symposium, Toulouse, France.

Anania, S., Rademaker, G., Wissocq, T., Bellahcene, A., Castronovo, V., & Peulen, O. (October 2019). Role of myoferlin in mitochondrial dynamics and metabolic fitness of PDAC [Poster presentation]. PANCREATIC CANCER SYMPOSIUM, Toulouse, France.

Costanza, B., Rademaker, G., Turtoi, A., Bellahcene, A., Castronovo, V., & Peulen, O. (October 2019). TGFBI, an ECM interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration [Poster presentation]. Pancreatic Cancer Symposium 2019, Toulouse, France.

Anania, S., Rademaker, G., Wissocq, T., Bellahcene, A., Castronovo, V., & Peulen, O. (06 September 2019). Role of myoferlin in mitochondrial dynamics and metabolic fitness of pancreas cancer [Poster presentation]. EDT Cancerology 2019, Bruxelles, Belgium.

Peulen, O., Rademaker, G., Anania, S., Turtoi, A., Bellahcene, A., & Castronovo, V. (August 2019). Ferlin overview: from membrane to cancer biology. Cells, 8, 954. doi:10.3390/cells8090954
Peer Reviewed verified by ORBi

Rademaker, G., Costanza, B., Anania, S., Agirman, F., Maloujahmoum, N., Bellahcene, A., Castronovo, V., & Peulen, O. (13 June 2019). Myoferlin Contributes to the Metastatic Phenotype of Pancreatic Cancer Cells by Enhancing Their Migratory Capacity Through the Control of Oxidative Phosphorylation [Poster presentation]. Belgian Society for Cell and Developmental Biology - Spring Meeting, Liège, Belgium.

Tiamiou, A., Dube, G., Bizet, M., Bellier, J., Deplus, R., Caprasse, M., Peulen, O., Castronovo, V., Fuks, F., & Bellahcene, A. (13 June 2019). A novel link between dicarbonyl stress and epigenetic regulation in breast cancer [Poster presentation]. Belgian Society for Cell and Developmental Biology (BSCDB), Liège, Belgium.

Rademaker, G., Costanza, B., Anania, S., Agirman, F., Maloujahmoum, N., Di Valentin, E., Goval, J.-J., Bellahcene, A., Castronovo, V., & Peulen, O. (June 2019). Myoferlin contributes to the metastatic phenotype of pancreatic cancer cells by enhancing their migratory capacity through the control of oxidative phosphorylation. Cancers, 11 (6). doi:10.3390/cancers11060853
Peer Reviewed verified by ORBi

Costanza, B., Rademaker, G., Tiamiou, A., De Tullio, P., Leenders, J., Blomme, A., Bellier, J., Bianchi, E., Turtoi, A., Delvenne, P., Bellahcene, A., Peulen, O.* , & Castronovo, V.*. (2019). TGFBI, an ECM interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration. International Journal of Cancer. doi:10.1002/ijc.32247
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Bellier, J., Nokin, M.-J., Lardé, E., Karoyan, P., Peulen, O., Castronovo, V., & Bellahcene, A. (2019). Methylglyoxal, a potent inducer of AGEs, connects between diabetes and cancer. Diabetes Research and Clinical Practice. doi:10.1016/j.diabres.2019.01.002
Peer Reviewed verified by ORBi

Nokin, M.-J., Bellier, J., Durieux, F., Peulen, O., Rademaker, G., Gabriel, M., Monseur, C., CHARLOTEAUX, B., Verbeke, L., van Laere, S., RONCARATI, P., Herfs, M., Lambert, C., Scheijen, J., Schalkwijk, C., Colige, A., Caers, J., Delvenne, P., Turtoi, A., ... Bellahcene, A. (2019). Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer. Breast Cancer Research, 21(1, 11. doi:10.1186/s13058-018-1095-7
Peer Reviewed verified by ORBi

Rademaker, G., Costanza, B., Bellier, J., Herfs, M., Agirman, F., Maloujahmoum, N., Bellahcene, A., Castronovo, V., & Peulen, O. (2019). Human colon cancer overexpress myoferlin to maintain a fit mitochondrial network and escape p53 dependent apoptosis [Poster presentation]. Belgian Association for Cancer Research Congress, Anvers, Belgium.

Rademaker, G., Costanza, B., Bellier, J., Herfs, M., Peiffer, R., Agirman, F., Maloujahmoum, N., Habraken, Y., Delvenne, P., Bellahcene, A., Castronovo, V.* , & Peulen, O.*. (2019). Human colon cancer cells highly express myoferlin to maintain a fit mitochondrial network and escape p53-driven apoptosis. Oncogenesis. doi:10.1038/s41389-019-0130-6
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Tiamiou, A., Durieux, F., Nokin, M.-J., Bellier, J., Ghanem, G., Journe, F., Arrese, E. J., Bellahcene, A., & Castronovo, V. (26 November 2018). Methylglyoxal-induced cardonyl stress in melanoma progression and response to therapy [Poster presentation]. Metabolism in cancer and Stromal Cells, Louvain, Belgium.

Tiamiou, A., Durieux, F., Nokin, M.-J., Bellier, J., Ghanem, G., Journé, F., Arrese, E. J., Bellahcene, A., & Castronovo, V. (28 September 2018). Methylglyoxal-induced cardonyl stress in melanoma progression and response to therapy [Poster presentation]. 3rd symposium of ULB - Cancer Research Center (U-CRC), Bruxelles, Belgium.

Tiamiou, A., Durieux, F., Nokin, M.-J., Bellier, J., Ghanem, G., Journé, F., Arrese, E. J., Bellahcene, A., & Castronovo, V. (13 September 2018). Methylglyoxal-induced cardonyl stress in melanoma progression and response to therapy [Poster presentation]. GIGA-Cancer Day 2018/EDT Cancerology, Liège, Belgium.

Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Herfs, M., Thiry, M., Bellahcene, A., Castronovo, V., & Peulen, O. (01 July 2018). Myoferlin controls mitochondrial structure and metabolism in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness [Poster presentation]. EACR 25 50 Years, Amsterdam, Netherlands.

Bellier, J., Nokin, M.-J., Durieux, F., Journe, F., Ghanem, G., Castronovo, V., & Bellahcene, A. (30 June 2018). Methylglyoxal-induced Dicarbonyl Stress: Role in Melanoma Progression and Response to Therapy [Poster presentation]. Bellier, Amsterdam, Netherlands.

Rademaker, G., Hennequière, V., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Bettendorff, L., Deroanne, C., Thiry, M., Delvenne, P., Hustinx, R., Bellahcene, A., Castronovo, V., & Peulen, O. (April 2018). Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness. Oncogene, 37 ((32)), 4398-4412. doi:10.1038/s41388-018-0287-z
Peer Reviewed verified by ORBi

Blomme, A., van Simaeys, G., Doumont, G., Costanza, B., Bellier, J., Otaka, Y., Sherer, F., LOVINFOSSE, P., Boutry, S., Palacios, A. P., De Pauw, E., Hirano, T., Yokobori, T., Hustinx, R., Bellahcene, A., Delvenne, P., DETRY, O., Goldman, S., Nishiyama, M., ... Turtoi, A. (March 2018). Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases. Oncogene, 37 (9), 1237-1250. doi:10.1038/s41388-017-0018-x
Peer Reviewed verified by ORBi

Bellier, J., Nokin, M.-J., Durieux, F., Peulen, O., Koji, U., Spiegel A, Cochrane R, Hutton A, C., Castronovo, V., & Bellahcene, A. (27 January 2018). Hormetic potential of Methylglyoxal in switching cancer cells from growth to death [Poster presentation]. Bellier, Liège, Belgium.

Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., Bellier, J., Costanza, B., Herfs, M., Bettendorff, L., Deroanne, C., Delvenne, P., HUSTINX, R., Bellahcene, A., Castronovo, V., & Peulen, O. (2018). Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma and affects tumor aggressiveness [Poster presentation]. Bioforum Uliège.

Bellahcene, A., Nokin, M.-J., Castronovo, V., & Schalkwijk, C. (2018). Methylglyoxal-derived stress: an emerging biological factor involved in the onset and progression of cancer. Seminars in Cancer Biology. doi:10.1016/j.semcancer.2017.05.010
Peer Reviewed verified by ORBi

Rademaker, G., Costanza, B., Bellier, J., Herfs, M., Agirman, F., Maloujahmoum, N., Bellahcene, A., Castronovo, V., & Peulen, O. (2018). Myoferlin depletion induces DNA damage response and p53 dependent cell cycle arrest and apoptosis in colon cancer [Poster presentation]. Third Symposium of UBRC, Bruxelles, Belgium.

Costanza, B., Turtoi, A., Bellahcene, A., Hirano, T., Peulen, O., Blomme, A., Hennequiere, J., MUTIJIMA NZARAMBA, E., Boniver, J., Meuwis, M.-A., JOSSE, C., KOOPMANSCH, B., SEGERS, K., Yokobori, T., Fahmy, K., Thiry, M., COIMBRA MARQUES, C., Garbacki, N., Colige, A., ... Castronovo, V. (2018). Innovative methodology for the identification of soluble biomarkers in fresh tissues. Oncotarget, 9 (12), 10665-10680. doi:10.18632/oncotarget.24366
Peer Reviewed verified by ORBi

Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Anania, S., Bettendorff, L., Deroanne, C., Thiry, M., Delvenne, P., HUSTINX, R., Bellahcene, A., Castronovo, V., & Peulen, O. (2018). Myoferlin controls mitochondrial structure and activity in pancreatic cancer and affects tumor aggressiveness [Poster presentation]. Belgian Association for Cancer Research Congress.

Bellier, J., Nokin, M.-J., Durieux, F., Peulen, O., Uchida, K., Spiegel A, D., Cochrane R, J., Hutton A, C., Castronovo, V., & Bellahcene, A. (19 October 2017). Hormetic potential of Methylglyoxal in switching cancer cells from growth to death [Poster presentation]. Bellier, Bertinoro, Italy.

Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Bettendorff, L., Deroanne, C., Delvenne, P., Hustinx, R., Bellahcene, A., Castronovo, V., & Peulen, O. (22 September 2017). Myoferlin controls mitochondrial structure in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness [Poster presentation]. Second U-CRC Symposium, Bruxelles, Belgium.

Rademaker, G., Hennequière, V., Peixoto, P., Bellahcene, A., Castronovo, V., & Peulen, O. (01 February 2017). Myoferlin, a new autophagy player in pancreatic cancer cells [Poster presentation]. Giga-Day, Liège, Belgium.

Chiavarina, B., Nokin, M.-J., Bellier, J., Durieux, F., BLETARD, N., Sherer, F., LOVINFOSSE, P., Peulen, O., Verset, L., Dehon, R., Demetter, P., Turtoi, A., Uchida, K., Goldman, S., Hustinx, R., Delvenne, P., Castronovo, V., & Bellahcene, A. (2017). Methylglyoxal-Mediated Stress Correlates with High Metabolic Activity and Promotes Tumor Growth in Colorectal Cancer. International Journal of Molecular Sciences, 18 (1). doi:10.3390/ijms18010213
Peer Reviewed verified by ORBi

Ebralidze, L., Mskhiladze, L., Ledoux, A., Frederich, M., Bellahcene, A., Bero, J., Quetin-Leclercq, J., & Bakuridze, A. (2017). ANTICANCER, ANTIPLASMODIAL AND ANTITRYPANOSOMAL ACTIVITIES OF CRUDE EXTRACTS OF PLATANUS ORIENTALIS. World Journal of Pharmaceutical Research, 6 (3), 170-175. doi:10.20959/wjpr20173-7985
Peer reviewed

Nokin, M.-J., Durieux, F., Bellier, J., Peulen, O., Uchida, K., Spiegel, D. A., Cochrane, J. R., Hutton, C. A., Castronovo, V., & Bellahcene, A. (2017). Hormetic potential of methylglyoxal, a side-product of glycolysis, in switching tumours from growth to death. Scientific Reports, 7 (1), 11722. doi:10.1038/s41598-017-12119-7
Peer Reviewed verified by ORBi

Blomme, A., Fahmy, K., Peulen, O., Costanza, B., Fontaine, M., Struman, I., Baiwir, D., De Pauw, E., Thiry, M., Bellahcene, A., Castronovo, V.* , & Turtoi, A.*. (2016). Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes. Oncotarget. doi:10.18632/oncotarget.13276
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Blomme, A., Costanza, B., De Tullio, P., Thiry, M., Van Simaeys, G., Boutry, S., Doumont, G., Di Valentin, E., Hirano, T., Yokobori, T., GOFFLOT, S., Peulen, O., Bellahcene, A., Sherer, F., Le Goff, C., Cavalier, E., Mouithys-Mickalad, A., Jouret, F., CUSUMANO, G., ... Turtoi, A. (2016). Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer. Oncogene. doi:10.1038/onc.2016.369
Peer Reviewed verified by ORBi

Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Turtoi, A., Costanza, B., Smargiasso, N., Baiwir, D., Scheijen, J., Schalkwijk, C., Leenders, J., De Tullio, P., BIANCHI, E., Thiry, M., Uchida, K., Spiegel, D., Cochrane, J., ... Bellahcene, A. (2016). Methylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP- mediated tumor growth and metastasis. eLife. doi:10.7554/eLife.19375
Peer Reviewed verified by ORBi

Henry, A., Nokin, M.-J., Leroi, N., Lallemand, F., Lambert, J., Goffart, N., RONCARATI, P., BIANCHI, E., Peixoto, P., Blomme, A., Turtoi, A., Peulen, O., Habraken, Y., Scholtes, F., Martinive, P., Delvenne, P., Rogister, B., Castronovo, V., & Bellahcene, A. (2016). New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity. Oncotarget. doi:10.18632/oncotarget.11483
Peer Reviewed verified by ORBi

Henry, A., Nokin, M.-J., Leroi, N., LALLEMAND, F., Lambert, J., Goffart, N., Peixoto, P., Blomme, A., BIANCHI, E., Habraken, Y., RONCARATI, P., Peulen, O., SCHOLTES, F., MARTINIVE, P., Rogister, B., Delvenne, P., Turtoi, A., Castronovo, V., & Bellahcene, A. (22 March 2016). Osteopontin predicts radiotherapy response of glioblastoma patients : new role in DNA damage repair [Paper presentation]. 3rd Symposium on small animal precision image-guided radiotherapy, Gand, Belgium.

Fradet, A., Bouchet, M., Delliaux, C., Gervais, M., Kan, C., Benetollo, C., Pantano, F., Vargas, G., Bouazza, L., Croset, M., Bala, Y., Leroy, X., Rosol, T. J., Rieusset, J., Bellahcene, A., Castronovo, V., Aubin, J. E., Clezardin, P., Duterque-Coquillaud, M., & Bonnelye, E. (2016). Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone. Oncotarget, 7 (47), 77071-77086. doi:10.18632/oncotarget.12787
Peer Reviewed verified by ORBi

Blomme, A., Cusumano, P., Peulen, O., Bellahcene, A., Castronovo, V., & Turtoi, A. (2016). L'asporine : une nouvelle defense naturelle contre le cancer du sein. MS. Medecine Sciences, 32 (11), 1019-1022. doi:10.1051/medsci/20163211020
Peer Reviewed verified by ORBi

Binsfeld, M., Muller, J., Lamour, V., De Veirman, K., De Raeve, H., Bellahcene, A., Van Valckenborgh, E., BARON, F., BEGUIN, Y., CAERS, J., & Heusschen, R. (2016). Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma. Oncotarget, 7, 37931-37943. doi:10.18632/oncotarget.9270
Peer Reviewed verified by ORBi

Fahmy, K., Gonzalez, A., Arafa, M., Peixoto, P., Bellahcene, A., Turtoi, A., Delvenne, P., Thiry, M., Castronovo, V., & Peulen, O. (2016). Myoferlin plays a key role in VEGFA secretion and impacts tumor-associated angiogenesis in human pancreas cancer. International Journal of Cancer, 138, 652-663. doi:10.1002/ijc.29820
Peer Reviewed verified by ORBi

Costanza, B., Blomme, A., Bellahcene, A., Peulen, O., MUTIJIMA NZARAMBA, E., DELVENNE, P., De Pauw, E., DETRY, O., COIMBRA MARQUES, C., Castronovo, V., & Turtoi, A. (2016). EXPEL: A Novel Non-Destructive Method for Mining Soluble Tumor Biomarkers. Acta Gastro-Enterologica Belgica, 79 (1), 11.
Peer Reviewed verified by ORBi

Peixoto, P.* , Blomme, A.* , Costanza, B.* , Ronca, R., Rezzola, S., Palacios, A., SCHOYSMAN, L., Boutry, S., Goffart, N., Peulen, O., Maris, P., Di Valentin, E., Hennequière, V., BIANCHI, E., Henry, A., Meunier, P., Rogister, B., MULLER, R., Delvenne, P., ... Turtoi, A. (2016). HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies. Oncogene. doi:10.1038/onc.2015.506
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Turtoi, A., Costanza, B., Smargiasso, N., Baiwir, D., Leenders, J., De Tullio, P., BIANCHI, E., Thiry, M., Uchida, K., Spiegel, D., Cochrane, J., Hutton, C., De Pauw, E., ... Bellahcene, A. (29 September 2015). Methylglyoxal, a glycolysis side-product, induces Hsp90 post-translational glycation and YAP-mediated breast tumor growth and metastasis [Poster presentation]. Cancer and Metabolism Conference, Cambridge, United Kingdom.

Durieux, F., Peixoto, P., Chiavarina, B., Nokin, M.-J., Karoyan, P., Castronovo, V., & Bellahcene, A. (28 September 2015). Characterization of new carbonyl scavenger molecules and their subsequent use for cancer therapy [Poster presentation]. Cancer and Metabolism Abcam 2015 Conference, Cambridge, United Kingdom.

Henry, A., Bellahcene, A., Castronovo, V., Peixoto, P., Goffart, N., Lallemand, F., Leroi, N., Peulen, O., MARTINIVE, P., Habraken, Y., Turtoi, A., Rogister, B., & Blomme, A. (Other coll.). (10 September 2015). Osteopontin as a new target in glioblastoma progression and resistance to radiotherapy [Paper presentation]. II International Symposium on clinical and basic investigation in glioblastoma, Toledo, Spain.

Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Smargiasso, N., De Tullio, P., BIANCHI, E., Baiwir, D., Thiry, M., Turtoi, A., De Pauw, E., DELVENNE, P., Castronovo, V., & Bellahcene, A. (09 September 2015). Methylglyoxal, a glycolysis side-product, induces Hsp90 post-translational glycation and YAP-mediated breast tumor growth and metastasis [Poster presentation]. Metabolism in Cancer and Stromal Cells, Leuven, Belgium.

Fahmy, K., Peulen, O., Castronovo, V., Bellahcene, A., Turtoi, A., Thiry, M., Delvenne, P., PEIXOTO, P., Gonzalez, A., & ARAFA, M. (31 January 2015). Myoferlin: an indispensable component in VEGFA secretion by pancreas cancer cells [Poster presentation]. ASSOCIATION BELGE POUR L'ETUDE DU CANCER, Bruxelles, Belgium.

Fahmy, K., Gonzalez, A., Arafad, M., Turtoi, A., Bellahcene, A., DELVENNE, P., Thiry, M., Castronovo, V., & Peulen, O. (27 January 2015). Myoferlin: an indispensable component in VEGR-A secretion by pancreatic cancer cell [Poster presentation]. GIGA-DAY: Current advances in medical genetics and genomics, Liège, Belgium.

Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Smargiasso, N., Baiwir, D., De Pauw, E., De Tullio, P., Thiry, M., Peulen, O., Turtoi, A., Castronovo, V., & Bellahcene, A. (27 January 2015). Accumulation of methylglyoxal, a glycolysis by-product modulates YAP1 transcription co-factor localization and activity in human breast cancer cells through HSP90 modification [Poster presentation]. GIGA-DAY: Current advances in medical genetics and genomics, Liège, Belgium.

Lamour, V., Henry, A., Kroonen, J., Nokin, M.-J., von Marschall, Z., Fisher, L., Chau, T.-L., Chariot, A., Sanson, M., Delattre, J.-Y., Turtoi, A., Peulen, O., Rogister, B., Castronovo, V., & Bellahcene, A. (2015). Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo. International Journal of Cancer. doi:10.1002/ijc.29454
Peer Reviewed verified by ORBi

Mskhiladze, L., Chincharadze, D., Tits, M., Wauters, J.-N., Bellahcene, A., Castronovo, V., Mouithys-Mickalad, A., Franck, T., & Frederich, M. (2015). Identification of Cytotoxic and Antioxidant Compounds from Allium gramineum Flowers. International Journal of Pharmaceutical Sciences and Drug Research, 7, 78-82.
Peer reviewed

Costanza, B., Blomme, A., Bellahcene, A., MUTIJIMA NZARAMBA, E., Peulen, O., & DELVENNE, P. (January 2015). EXPEL: A Novel Non-Destructive Method for Mining Soluble Tumor Biomarkers [Poster presentation]. Belgian Association Cancer Research.

Maris, P., Blomme, A., Palacios, A. P., Costanza, B., Bellahcene, A., BIANCHI, E., GOFFLOT, S., Drion, P., Trombino, G. E., Di Valentin, E., CUSUMANO, G., MAWEJA, S., JERUSALEM, G., Delvenne, P., LIFRANGE, E., Castronovo, V., & Turtoi, A. (2015). Asporin Is a Fibroblast-Derived TGF-beta1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer. PLoS Medicine, 12 (9), 1001871. doi:10.1371/journal.pmed.1001871
Peer Reviewed verified by ORBi

Turtoi, A., Peixoto, P., Castronovo, V., & Bellahcene, A. (2015). Histone deacetylases and cancer-associated angiogenesis: current understanding of the biology and clinical perspectives. Critical Reviews in Oncogenesis, 20 (1-2), 119-37. doi:10.1615/CritRevOncog.2014012423
Peer Reviewed verified by ORBi

Chiavarina, B.* , Nokin, M.-J.* , Durieux, F., BIANCHI, E., Turtoi, A., Peulen, O., Peixoto, P., Irigaray, P., Uchida, K., Belpomme, D., Delvenne, P., Castronovo, V., & Bellahcene, A. (2014). Triple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypes. Oncotarget. doi:10.18632/oncotarget.2121
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Costanza, B., Blomme, A., Bellahcene, A., Hennequière, V., LIFRANGE, E., DELVENNE, P., Castronovo, V., & Turtoi, A. (2014). Myoferlin is a Key Regulator of HER Receptor Family Function in Breast Cancer [Paper presentation]. EDT Annual Mini symposium 2014.

Tilli, T. M., Bellahcene, A., Castronovo, V., & Gimba, E. R. P. (2014). Changes in the transcriptional profile in response to overexpression of the osteopontin-c splice isoform in ovarian (OvCar-3) and prostate (PC-3) cancer cell lines. BMC Cancer, 14, 433. doi:10.1186/1471-2407-14-433
Peer Reviewed verified by ORBi

Binsfeld, M., Heusschen, R., Lamour, V., Van Valckenborgh, E., Bellahcene, A., Baron, F., BEGUIN, Y., & CAERS, J. (2014). Multiple myeloma cells instruct myeloid-derived suppressor cells to release pro-angiogenic cytokines. Belgian Journal of Hematology.

Pesesse, L., Sanchez, C., Delcour, J.-P., Bellahcene, A., Baudouin, C., Msika, P., & Henrotin, Y. (November 2013). ASSOCIATION BETWEEN CHONDROCYTE HYPERTROPHY AND ANGIOGENESIS OF CARTILAGE IN OSTEOARTHRITIS [Paper presentation]. Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases.

Lamour, V., Nokin, M.-J., Henry, A., Castronovo, V., & Bellahcene, A. (2013). Les proteines SIBLING - Outils moleculaires de la progression tumorale et de l'angiogenese. MS. Medecine Sciences, 29 (11), 1018-25. doi:10.1051/medsci/20132911019
Peer Reviewed verified by ORBi

Pesesse, L., Sanchez, C., Delcour, J.-P., Bellahcene, A., Baudouin, C., Msika, P., & Henrotin, Y. (2013). Consequences of chondrocyte hypertrophy on osteoarthritic cartilage: potential effect on angiogenesis. Osteoarthritis and Cartilage, 21 (12), 1913-23. doi:10.1016/j.joca.2013.08.018
Peer Reviewed verified by ORBi

Turtoi, A.* , Blomme, A.* , Bellahcene, A., Gilles, C., Hennequière, V., Peixoto, P., BIANCHI, E., Noël, A., De Pauw, E., LIFRANGE, E., Delvenne, P., & Castronovo, V. (2013). Myoferlin is a key regulator of EGFR activity in breast cancer. Cancer Research, 73, 5438-5448. doi:10.1158/0008-5472.CAN-13-1142
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

bournine, L., Bensalem, S., Wauters, J.-N., Iguer-Ouada, M., Maiza-Benabdesselam, F., Bedjou, F., Castronovo, V., Bellahcene, A., Tits, M., & Frederich, M. (2013). Identification and Quantification of the Main Active Anticancer Alkaloids from the Root of Glaucium flavum. International Journal of Molecular Sciences, 14, 23533-23544. doi:10.3390/ijms141223533
Peer Reviewed verified by ORBi

Bournine, L., Bensalem, S., Peixoto, P., Gonzalez, A., Maiza-Benabdesselam, F., Bedjou, F., Wauters, J.-N., Tits, M., Frederich, M., Castronovo, V., & Bellahcene, A. (2013). Revealing the anti-tumoral effect of Algerian Glaucium flavum roots against human cancer cells. Phytomedicine, 20 (13), 1211-1218. doi:10.1016/j.phymed.2013.06.007
Peer Reviewed verified by ORBi

Fradet, A., Sorel, H., Depalle, B., Serre, C. M., Farlay, D., Turtoi, A., Bellahcene, A., Follet, H., Castronovo, V., Clezardin, P., & Bonnelye, E. (2013). A new murine model of osteoblastic/osteolytic lesions from human androgen-resistant prostate cancer. PLoS ONE, 8 (9), 75092. doi:10.1371/journal.pone.0075092
Peer Reviewed verified by ORBi

Castronovo, V., Matheus, N., Dumont, B., Peixoto, P., Hennequière, V., Deroanne, C., Colige, A., De Pauw, E., Bellahcene, A., Mottet, D., & Turtoi, A. (21 April 2012). The angiogenesis suppressor gene AKAP12 is under the epigenetic control of HDAC7 in endothelial cells [Paper presentation]. Experimental Biology 2012, SAN DIEGO, United States.

Castronovo, V., Bellahcene, A., & Pirotte, S. (02 February 2012). Dentin Matrix Protein 1 (DMP1) for use in pharmaceutical compositions.

Dumont, B., Castronovo, V., Peulen, O., BLETARD, N., Clézardin, P., Delvenne, P., De Pauw, E., Turtoi, A., & Bellahcene, A. (2012). Differential proteomic analysis of a human breast tumor and its matched bone metastasis identifies cell membrane and extracellular proteins associated with bone metastasis. Journal of Proteome Research. doi:10.1021/pr201022n
Peer Reviewed verified by ORBi

Tilli, T. M., Mello, K. D., Ferreira, L. B., Matos, A. R., Accioly, M. T., Faria, P. A., Bellahcene, A., Castronovo, V., & Gimba, E. R. (2012). Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells. Prostate. doi:10.1002/pros.22523
Peer Reviewed verified by ORBi

Mathieu, V., de Lassalle, E. M., Toelen, J., Mohr, T., Bellahcene, A., Van, G., Verschuere, T., Bouzin, C., Debyser, Z., De Vleesschouwer, S., Van Gool, S., Poirier, F., Castronovo, V., Kiss, R., & Feron, O. (2012). Galectin-1 in Melanoma Biology and Related Neo-Angiogenesis Processes. Journal of Investigative Dermatology. doi:10.1038/jid.2012.142
Peer Reviewed verified by ORBi

Turtoi, A., Mottet, D., Matheus, N., Dumont, B., Peixoto, P., Hennequière, V., Deroanne, C., Colige, A., De Pauw, E., Bellahcene, A., & Castronovo, V. (2012). The angiogenesis suppressor gene AKAP12 is under the epigenetic control of HDAC7 in endothelial cells. Angiogenesis. doi:10.1007/s10456-012-9279-8
Peer Reviewed verified by ORBi

Kischel, P., Bellahcene, A., Deux, B., Lamour, V., Dobson, R., De Pauw, E., Clezardin, P., & Castronovo, V. (2012). Overexpression of CD9 in human breast cancer cells promotes the development of bone metastases. Anticancer Research, 32 (12), 5211-20.
Peer Reviewed verified by ORBi

Fradet, A., Sorel, H., Bouazza, L., Goehrig, D., Depalle, B., Bellahcene, A., Castronovo, V., Follet, H., Descotes, F., Aubin, J. E., Clezardin, P., & Bonnelye, E. (2011). Dual function of ERR alpha in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin. Cancer Research, 71 (17), 5728-38. doi:10.1158/0008-5472.CAN-11-1431
Peer Reviewed verified by ORBi

Sin, S., Bonin, F., Petit, V., Meseure, D., Lallemand, F., Bieche, I., Bellahcene, A., Castronovo, V., de Wever, O., Gespach, C., Lidereau, R., & Driouch, K. (2011). Role of the Focal Adhesion Protein Kindlin-1 in Breast Cancer Growth and Lung Metastasis. Journal of the National Cancer Institute, 103, 1-15. doi:10.1093/jnci/djr290
Peer Reviewed verified by ORBi

Pirotte, S., Lamour, V., Lambert, V., Alvarez Gonzalez, M.-L., Ormenese, S., Noël, A., Mottet, D., Castronovo, V., & Bellahcene, A. (2011). Dentin Matrix Protein 1 induces membrane expression of VE-cadherin on endothelial cells and inhibits VEGF-induced angiogenesis by blocking VEGFR-2 phosphorylation. Blood, 117 (8), 2515-26. doi:10.1182/blood-2010-08-298810
Peer Reviewed verified by ORBi

Stresing, V., Fournier, P. G., Bellahcene, A., Benzaid, I., Monkkonen, H., Colombel, M., Ebetino, F. H., Castronovo, V., & Clezardin. (2011). Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase. BONE, 48 (2), 259-66. doi:10.1016/j.bone.2010.09.035
Peer Reviewed verified by ORBi

Shiva Shankar, T. V., Sulka, B., Blacher, S., Maillard, C., Noël, A., Bellahcene, A., Castronovo, V., Lambert, D., Wouters, J., & Willems, L. (2010). Novel HDAC/DNMT twin inhibitors interfere with angiogenesis [Poster presentation]. Keystone Symposia on Molecular and Cellular Biology.

Lamour, V., Le Mercier, M., Lefranc, F., Hagedorn, M., Javerzat, S., Bikfalvi, A., Kiss, R., Castronovo, V., & Bellahcene, A. (2010). Selective osteopontin knockdown exerts anti-tumoral activity in a human glioblastoma model. International Journal of Cancer, 126, 1797-1805. doi:10.1002/ijc.24751
Peer Reviewed verified by ORBi

Mottet, D., Pirotte, S., Lamour, V., Hagedorn, M., Javerzat, S., Bikfalvi, A., Bellahcene, A., Castronovo, V., & Verdin, E. (2009). HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism. Oncogene, 28 (2), 243-56. doi:10.1038/onc.2008.371
Peer Reviewed verified by ORBi

Bellahcene, A., Castronovo, V., Ogbureke, K. U., Fisher, L. W., & Fedarko, N. S. (March 2008). Small Integrin-Binding Ligand N-Linked Glycoproteins (Siblings): Multifunctional Proteins in Cancer. Nature Reviews. Cancer, 8 (3), 212-26. doi:10.1038/nrc2345
Peer Reviewed verified by ORBi

Detry, C., Lamour, V., Castronovo, V., & Bellahcene, A. (February 2008). Creb-1 and Ap-1 Transcription Factors Jund and Fra-2 Regulate Bone Sialoprotein Gene Expression in Human Breast Cancer Cells. BONE, 42 (2), 422-31. doi:10.1016/j.bone.2007.10.016
Peer Reviewed verified by ORBi

Sanchez, C., Deberg, M., Bellahcene, A., Castronovo, V., Msika, P., Delcour, J.-P., Crielaard, J.-M., & Henrotin, Y. (February 2008). Phenotypic Characterization of Osteoblasts from the Sclerotic Zones of Osteoarthritic Subchondral Bone. Arthritis and Rheumatism, 58 (2), 442-55. doi:10.1002/art.23159
Peer Reviewed verified by ORBi

Landemaine, T., Jackson, A., Bellahcene, A., Rucci, N., Sin, S., Abad, B. M., Sierra, A., Boudinet, A., Guinebretiere, J.-M., Ricevuto, E., Nogues, C., Briffod, M., Bieche, I., Cherel, P., Garcia, T., Castronovo, V., Teti, A., Lidereau, R., & Driouch, K. (2008). A six-gene signature predicting breast cancer lung metastasis. Cancer Research, 68 (15), 6092-9. doi:10.1158/0008-5472.CAN-08-0436
Peer Reviewed verified by ORBi

Saidi, A., Javerzat, S., Bellahcene, A., De Vos, J., Bello, L., Castronovo, V., Deprez, M., Loiseau, H., Bikfalvi, A., & Hagedorn, M. (2008). Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma. International Journal of Cancer, 122 (10), 2187-98. doi:10.1002/ijc.23313
Peer Reviewed verified by ORBi

Kischel, P., Guillonneau, F., Dumont, B., Bellahcene, A., Stresing, V., Clezardin, P., De Pauw, E., & Castronovo, V. (2008). Cell membrane proteomic analysis identifies proteins differentially expressed in osteotropic human breast cancer cells. Neoplasia, 10 (9), 1014-20. doi:10.1593/neo.08570
Peer Reviewed verified by ORBi

Lamour, V., Detry, C., Sanchez, C., Henrotin, Y., Castronovo, V., & Bellahcene, A. (14 December 2007). Runx2-and histone deacetylase 3-mediated repression is relieved in differentiating human osteoblast cells to allow high bone sialoprotein expression. Journal of Biological Chemistry, 282 (50), 36240-36249. doi:10.1074/jbc.M705833200
Peer Reviewed verified by ORBi

Mottet, D., Bellahcene, A., Pirotte, S., Waltregny, D., Deroanne, C., Lamour, V., Lidereau, R., & Castronovo, V. (07 December 2007). Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis. Circulation Research, 101 (12), 1237-1246. doi:10.1161/CIRCRESAHA.107.149377
Peer Reviewed verified by ORBi

Le Gall, C., Bellahcene, A., Bonnelye, E., Gasser, J. A., Castronovo, V., Green, J., Zimmermann, J., & Clezardin, P. (15 October 2007). A cathepsin K inhibitor reduces breast cancer-induced osteolysis and skeletal tumor burden. Cancer Research, 67 (20), 9894-9902. doi:10.1158/0008-5472.CAN-06-3940
Peer Reviewed verified by ORBi

Bucciarelli, E., Sidoni, A., Bellezza, G., Cavaliere, A., Brachelente, G., Costa, G., Chaplet, M., Castronovo, V., & Bellahcene, A. (September 2007). Low dentin matrix protein 1 expression correlates with skeletal metastases development in breast cancer patients and enhances cell migratory capacity in vitro. Breast Cancer Research and Treatment, 105 (1), 95-104. doi:10.1007/s10549-006-9436-0
Peer Reviewed verified by ORBi

Bellahcene, A., Chaplet, M., Bonjean, K., & Castronovo, V. (2007). Zoledronate inhibits alpha v beta 3 and alpha v beta 5 integrin cell surface expression in endothelial cells. Endothelium: Journal of Endothelial Cell Research, 14 (2), 123-130. doi:10.1080/10623320701347187
Peer Reviewed verified by ORBi

Bellahcene, A., Bachelier, R., Detry, C., Lidereau, R., Clezardin, P., & Castronovo, V. (January 2007). Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells. Breast Cancer Research and Treatment, 101 (2), 135-148. doi:10.1007/s10549-006-9279-8
Peer Reviewed verified by ORBi

Sanchez, C., Deberg, M., Bellahcene, A., Castronovo, V., Msika, P., & Henrotin, Y. (2007). Phenotypic characterisation of osteoblasts from the sclerotic zone of human osteoarthritic subchondral bone [Poster presentation]. 27th European Workshop for Rheumatology Research, Barcelona, Spain.

Delmulle, L., Bellahcene, A., Dhooge, W., Comhaire, F., Roelens, F., Huvaere, K., Heyerick, A., Castronovo, V., & De Keukeleire, D. (November 2006). Anti-proliferative properties of prenylated flavonoids from hops (Humulus lupulus L.) in human prostate cancer cell lines. Phytomedicine, 13 (9-10), 732-734. doi:10.1016/j.phymed.2006.01.001
Peer Reviewed verified by ORBi

de Leval, X., Dassesse, T., Dogné, J.-M., Waltregny, D., Bellahcene, A., Benoit, V., Pirotte, B., & Castronovo, V. (September 2006). Evaluation of original dual thromboxane A2 modulators as antiangiogenic agents. Journal of Pharmacology and Experimental Therapeutics, 318 (3), 1057-1067. doi:10.1124/jpet.106.101188
Peer Reviewed verified by ORBi

Chaplet, M., Waltregny, D., Detry, C., Fisher, L., Castronovo, V., & Bellahcene, A. (February 2006). Expression of dentin sialophosphoprotein in human prostate cancer and its correlation with tumor aggressiveness. International Journal of Cancer, 118 (4), 850-856. doi:10.1002/ijc.21442
Peer Reviewed verified by ORBi

Mottet, D., Bellahcene, A., Waltregny, D., Lidereau, R., & Castronovo, V. (20 January 2006). Histone deacetylase HDAC7 as a key regulator of the angiogenic process [Poster presentation]. Annual meeting of the European STROMA consortium, Paris, France.

Sanchez, C., Deberg, M., Bellahcene, A., Castronovo, V., Msika, P., & Henrotin, Y. (2006). Caractérisation du phénotype des ostéoblastes issus des zones sclérosées de l’os sous-chondral arthrosique humain. Revue du Rhumatisme, 73 (10-11), 1058.
Peer Reviewed verified by ORBi

Sanchez, C., Deberg, M., Bellahcene, A., Castronovo, V., Msika, P., & Henrotin, Y. (2006). Phenotypic characterisation of osteoblasts from the sclerotic zone of human osteoarthritic subchondral bone. Osteoarthritis and Cartilage, 14 (Suppl B), 75.
Peer Reviewed verified by ORBi

Mottet, D., Bellahcene, A., Deroanne, C., Lamour, V., Waltregny, D., & Castronovo, V. (2006). Histone deacetylase 7 is involved in the control of angiogenesis by regulating platelet-derived growth factor-β [Paper presentation]. Les Journées du CRCE, Liège, Belgium.

Dassesse, T., de Leval, X., Dogné, J.-M., Waltregny, D., Bellahcene, A., Pirotte, B., & Castronovo, V. (2006). Evaluation of original dual thromboxane A2 modulators as anti-angiogenic agents [Paper presentation]. Les Journées du CRCE, Liège, Belgium.

Waltregny, D., Chaplet, M., Detry, C., Fisher, L., Castronovo, V., & Bellahcene, A. (2005). Expression of dentin sialophosphoprotein in human prostate cancer and its correlation with tumor aggressiveness [Paper presentation]. Gordon Research Conference on SIBLINGs, Big Sky, MT, United States.

Chaplet, M., Waltregny, D., Detry, C., Fisher, L., Castronovo, V., & Bellahcene, A. (2005). Dentin sialophosphoprotein expression correlates with progression markers in human prostate cancer [Paper presentation]. Meeting of the Paget’s foundation, Bethesda, MA, United States.

Chaplet, M., Waltregny, D., Detry, C., Fisher, L., Castronovo, V., & Bellahcene, A. (2005). Dentin sialophosphoprotein expression correlates with progression markers in human prostate cancer. Journal of Bone and Mineral Research, 20 (Suppl. 2), 45.
Peer Reviewed verified by ORBi

Chaplet, M., Deroanne, C., Fisher, L. W., Castronovo, V., Bellahcene, A., & Detry, C. (15 December 2004). Zoledronic acid up-regulates bone sialoprotein expression in osteoblastic cells through Rho GTPase inhibition. Biochemical Journal, 384 (Pt 3), 591-598. doi:10.1042/BJ20040380
Peer Reviewed verified by ORBi

Waltregny, D., de Leval, L., Glenisson, W., Ly Tran, S., North, B., Bellahcene, A., Weidle, U., & Castronovo, V. (August 2004). Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues. American Journal of Pathology, 165 (2), 553-564. doi:10.1016/S0002-9440(10)63320-2
Peer Reviewed verified by ORBi

Chaplet, M., de Leval, L., Waltregny, D., Detry, C., Fornaciari, G., Bevilacqua, G., Fisher, L., Castronovo, V., & Bellahcene, A. (August 2003). Dentin matrix protein 1 is expressed in human lung cancer. Journal of Bone and Mineral Research, 18 (8), 1506-1512. doi:10.1359/jbmr.2003.18.8.1506
Peer Reviewed verified by ORBi

Detry, C., Waltregny, D., Quatresooz, P., Chaplet, M., Kedzia, W., Castronovo, V., Delvenne, P., & Bellahcene, A. (July 2003). Detection of bone sialoprotein in human (pre)neoplastic lesions of the uterine cervix. Calcified Tissue International, 73 (1), 9-14. doi:10.1007/s00223-002-2108-0
Peer Reviewed verified by ORBi

Barnes, G. L., Javed, A., Waller, S. M., Kamal, M. H., Hebert, K. E., Hassan, M. Q., Bellahcene, A., van Wijnen, A. J., Young, M. F., Lian, J. B., Stein, G. S., & Gerstenfeld, L. C. (15 May 2003). Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. Cancer Research, 63 (10), 2631-2637.
Peer Reviewed verified by ORBi

Wood, J., Bonjean, K., Ruetz, S., Bellahcene, A., Devy, L., Foidart, J.-M., Castronovo, V., & Green, J. R. (September 2002). Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. Journal of Pharmacology and Experimental Therapeutics, 302 (3), 1055-1061. doi:10.1124/jpet.102.035295
Peer Reviewed verified by ORBi

Castronovo, V., Waltregny, D., Fisher, L., & Bellahcene, A. (2002). The role of bone sialoprotein and other members of the SIBLING family in bone metastases formation. In 3rd International Conference on Osteopontin and SIBLING (Small Integrin-Binding Ligand, N-linked Glycoprotein) Proteins (pp. 195-197). The Scientific World eBook. doi:10.1100/tsw.2002.323

Detry, C., Castronovo, V., Waltregny, D., Delvenne, P., & Bellahcene, A. (2002). Detection of bone sialoprotein in human (pre)neoplastic lesions of the uterine cervix [Paper presentation]. Annual meeting of the Belgian Association for Cancer Research, Bruxelles, Belgium.

De Pinieux, G., Flam, T., Zerbib, M., Taupin, P., Bellahcene, A., Waltregny, D., Vieillefond, A., & Poupon, M.-F. (2001). Bone sialoprotein, bone morphogenetic protein 6 and thymidine phosphorylase expression in localized human prostatic adenocarcinoma as predictors of clinical outcome: a clinicopathological and immunohistochemical study of 43 cases. Journal of Urology, 166 (5), 1924-30. doi:10.1016/S0022-5347(05)65722-9
Peer Reviewed verified by ORBi

Bellahcene, A., Van Riet, I., de Greef, C., Antoine, N., Young, M. F., Van Camp, B., & Castronovo, V. (December 2000). Bone Sialoprotein Mrna and Protein Expression in Human Multiple Myeloma Cell Lines and Patients. British Journal of Haematology, 111 (4), 1118-21. doi:10.1046/j.1365-2141.2000.02506.x
Peer Reviewed verified by ORBi

Waltregny, D., Bellahcene, A., de Leval, X., Florkin, B., Weidle, U., & Castronovo, V. (May 2000). Increased Expression of Bone Sialoprotein in Bone Metastases Compared with Visceral Metastases in Human Breast and Prostate Cancers. Journal of Bone and Mineral Research, 15 (5), 834-43. doi:10.1359/jbmr.2000.15.5.834
Peer Reviewed verified by ORBi

Bellahcene, A., Bonjean, K., Fohr, B., Fedarko, N. S., Robey, F. A., Young, M. F., Fisher, L. W., & Castronovo, V. (28 April 2000). Bone Sialoprotein Mediates Human Endothelial Cell Attachment and Migration and Promotes Angiogenesis. Circulation Research, 86 (8), 885-91. doi:10.1161/01.RES.86.8.885
Peer Reviewed verified by ORBi

Bellahcene, A., Waltregny, D., & Castronovo, V. (1999). The role of bone sialoprotein in bone metastasis. In G. G. Skouteris & G. L. Nicolson (Eds.), Intermolecular Cross-Talk in Tumor Metastasis. Amsterdam, Netherlands: IOS Press.

Waltregny, D., Bellahcene, A., de Leval, X., & Castronovo, V. (1999). Increased expression of bone sialoprotein in skeletal metastases compared with non skeletal metastases from human breast and prostate cancers [Paper presentation]. Annual meeting of the Belgian Association for Cancer Research, Anvers, Belgium.

Bellahcene, A., Waltregny, D., & Castronovo, V. (1999). The role of bone sialoprotein in bone metastasis [Paper presentation]. 26th European Symposium on Calcified Tissues, Maastricht, Netherlands.

Bellahcene, A., Waltregny, D., & Castronovo, V. (1999). The role of bone sialoprotein in the process of bone metastases development. Amsterdam, Netherlands: IOS Press.

Bellahcene, A., Albert, V., Pollina, L., Basolo, F., Fisher, L. W., & Castronovo, V. (August 1998). Ectopic Expression of Bone Sialoprotein in Human Thyroid Cancer. Thyroid, 8 (8), 637-41. doi:10.1089/thy.1998.8.637
Peer Reviewed verified by ORBi

Waltregny, D., Bellahcene, A., Van Riet, I., Fisher, L. W., Young, M., Fernandez, P., Dewé, W., de Leval, J., & Castronovo, V. (01 July 1998). Prognostic Value of Bone Sialoprotein Expression in Clinically Localized Human Prostate Cancer. Journal of the National Cancer Institute, 90 (13), 1000-8. doi:10.1093/jnci/90.13.1000
Peer Reviewed verified by ORBi

Castronovo, V., & Bellahcene, A. (February 1998). Evidence That Breast Cancer Associated Microcalcifications Are Mineralized Malignant Cells. International Journal of Oncology, 12 (2), 305-8. doi:10.3892/ijo.12.2.305
Peer Reviewed verified by ORBi

Waltregny, D., Bellahcene, A., Van Riet, I., Fisher, L., Fernandez, P., Dewé, de Leval, J., & Castronovo, V. (23 January 1998). Expression of bone sialoprotein in human prostate is associated with progression [Paper presentation]. 5th Euregional Oncology meeting, Maastricht, Netherlands.

Waltregny, D., Bellahcene, A., de Leval, X., & Castronovo, V. (1998). Detection of bone sialoprotein in primary and metastatic lesions of human breast and prostate carcinomas, the two major osteotropic cancers. Revue du Rhumatisme, 7-9, 527.
Peer Reviewed verified by ORBi

Waltregny, D., Bellahcene, A., Van Riet, I., Fisher, L., Fernandez, P., Dewé, W., de Leval, J., & Castronovo, V. (1998). Expression of bone sialoprotein in human prostate cancer is associated with progression. Proceedings of the American Association for Cancer Research, 39, 322.
Peer reviewed

Bellahcene, A., Albert, V., Nyabi, O., Cheung, N. K. V., Kramer, K., Waltregny, D., Fisher, L., & Castronovo, V. (1998). Bone sialoprotein is expressed in both human neuroblastoma tissues and cell lines. Proceedings of the American Association for Cancer Research, 39, 209.
Peer reviewed

Waltregny, D., Bellahcene, A., Van Riet, I., Fisher, L., Fernandez, P., Dewé, W., de Leval, J., & Castronovo, V. (January 1998). Expression of bone sialoprotein in human prostate cancer is associated with progression. Acta Clinica Belgica, 53 (3), 221-240.
Peer Reviewed verified by ORBi

Bellahcene, A., Maloujahmoum, N., Fisher, L. W., Pastorino, H., Tagliabue, E., Menard, S., & Castronovo, V. (September 1997). Expression of Bone Sialoprotein in Human Lung Cancer. Calcified Tissue International, 61 (3), 183-8. doi:10.1007/s002239900320
Peer Reviewed verified by ORBi

van den Brûle, F., Bellahcene, A., Jackers, P., Liu, F.-T., Sobel, M. E., & Castronovo, V. (1997). Antisense galectin-3 alters thymidine incorporation in human MDA-MB435 breast cancer cells. International Journal of Oncology, 11 (2), 261-264. doi:10.3892/ijo.11.2.261
Peer Reviewed verified by ORBi

Bellahcene, A., & Castronovo, V. (January 1997). Expression of Bone Matrix Proteins in Human Breast Cancer: Potential Roles in Microcalcification Formation and in the Genesis of Bone Metastases. Bulletin du Cancer, 84 (1), 17-24.
Peer Reviewed verified by ORBi

Bellahcene, A., Menard, S., Bufalino, R., Moreau, L., & Castronovo, V. (22 August 1996). Expression of Bone Sialoprotein in Primary Human Breast Cancer Is Associated with Poor Survival. International Journal of Cancer, 69 (4), 350-3. doi:10.1002/(SICI)1097-0215(19960822)69:4<350::AID-IJC19>3.0.CO;2-9
Peer Reviewed verified by ORBi

Bellahcene, A., Antoine, N., Clausse, N., Tagliabue, E., Fisher, L. W., Kerr, J. M., Jares, P., & Castronovo, V. (August 1996). Detection of Bone Sialoprotein in Human Breast Cancer Tissue and Cell Lines at Both Protein and Messenger Ribonucleic Acid Levels. Laboratory Investigation, 75 (2), 203-10.
Peer Reviewed verified by ORBi

Bellahcene, A., Kroll, M., Liebens, F., & Castronovo, V. (May 1996). Bone Sialoprotein Expression in Primary Human Breast Cancer Is Associated with Bone Metastases Development. Journal of Bone and Mineral Research, 11 (5), 665-70. doi:10.1002/jbmr.5650110514
Peer Reviewed verified by ORBi

Dejardin, E., Bonizzi, G., Bellahcene, A., Castronovo, V., Merville, M.-P., & Bours, V. (02 November 1995). Highly-Expressed P100/P52 (Nfkb2) Sequesters Other Nf-Kappa B-Related Proteins in the Cytoplasm of Human Breast Cancer Cells. Oncogene, 11 (9), 1835-41.
Peer Reviewed verified by ORBi

Bellahcene, A., & Castronovo, V. (January 1995). Increased Expression of Osteonectin and Osteopontin, Two Bone Matrix Proteins, in Human Breast Cancer. American Journal of Pathology, 146 (1), 95-100.
Peer Reviewed verified by ORBi

Bellahcene, A., Merville, M.-P., & Castronovo, V. (01 June 1994). Expression of Bone Sialoprotein, a Bone Matrix Protein, in Human Breast Cancer. Cancer Research, 54 (11), 2823-6.
Peer Reviewed verified by ORBi

Bellahcene, A., Merville, M.-P., Gielen Jacques, Lambotte, R., Simar, L., & Castronovo, V. (01 May 1994). La protéine P53, protectrice de l'intégrité du génome: rôle dans la genèse des cancers. Revue Médicale de Liège, 49 (5), 274-84.
Peer reviewed

Contact ORBi